Oxeia Biopharmaceuticals develops novel therapeutics for patients with concussions.Because rest is not enough What’s New… Oxeia Biopharma In the News Concussion Drug Therapies on the Horizon Game on for Concussion Therapies KU Medical Center researcher testing drug to improve concussion symptoms CONCUSSION DRUG STUDY SHOWS POSITIVE EARLY RESULTS The injection of Ghrelin (OXE-103) improves subacute concussion symptom burden and quality of life These stories and more… Read more... Oxeia Biopharmaceuticals is a team of passionate scientists, biotech leaders, and athletes dedicated to bringing a safe and effective concussion therapy to market.REST IS NOT ENOUGH. More About What We Do